Suppr超能文献

[卡托普利增强的锝-99m二乙三胺五醋酸肾动态显像在肾血管性高血压患者中的应用]

[Captopril-enhanced renography using 99mTc-DTPA in renovascular hypertensive patients].

作者信息

Itoh K, Kakizaki H, Kato C, Tsukamoto E, Nakada K, Nagao K, Togashi M, Furudate M

机构信息

Department of Nuclear Medicine, Hokkaido University School of Medicine.

出版信息

Kaku Igaku. 1990 Apr;27(4):363-71.

PMID:2198369
Abstract

Dynamic renal scintigraphy with 99mTc-DTPA before (baseline renography: BS-RG) and 1 hour after administration of 25 mg to 50 mg of captopril (captopril-enhanced renography: CP-RG) was performed in a selected series of 18 patients suspected of having renovascular hypertension. Final diagnosis was made by angiography and further clinical follow-up. Eight patients were considered as renovascular hypertension (RVH), 6 with bilateral renal artery stenosis (BRAS) and 2 with unilateral renal artery stenosis (URAS). The remaining 10 patients were non-renovascular (non-RVH). Two criteria were prospectively employed for evaluating positive response induced by captopril. Glomerular filtration rate (GFR) on BS-RG (GFRbase) and on CP-RG (GFRcap) was estimated by early (120-180 seconds) DTPA uptake by the kidney, and then captopril response rate (CRR) was calculated in the following: CRR = (GFRcap-GFRbase)/GFRbase X 100 (%). CP-RG was considered positive when it was less than 20%. Renogram shape was also independently evaluated. CP-RG was also considered positive when either a delay of time to peak activity of more than 5 min or conversion of renogram shape to an obstructive or non-functioning pattern was observed. The sensitivity and specificity of CRR and change in renogram were 50% and 80%, 63% and 100%, respectively. In BRAS, positive response was observed in the unilateral kidney alone which maintained relatively a good renal function. CP-RG could not differentiate RVH with URAS from that with BRAS. Four patients were followed after the surgical or angioplastic treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对18例疑似肾血管性高血压的患者进行了动态肾闪烁扫描,分别在服用25毫克至50毫克卡托普利前(基线肾图:BS-RG)和服用后1小时(卡托普利增强肾图:CP-RG)使用99mTc-DTPA。最终诊断通过血管造影和进一步的临床随访确定。8例患者被诊断为肾血管性高血压(RVH),其中6例为双侧肾动脉狭窄(BRAS),2例为单侧肾动脉狭窄(URAS)。其余10例患者为非肾血管性(非RVH)。前瞻性地采用了两个标准来评估卡托普利诱导的阳性反应。通过肾脏早期(120 - 180秒)摄取DTPA来估计BS-RG(GFRbase)和CP-RG(GFRcap)时的肾小球滤过率(GFR),然后按以下公式计算卡托普利反应率(CRR):CRR = (GFRcap - GFRbase)/GFRbase × 100 (%)。当CRR小于20%时,CP-RG被认为是阳性。还对肾图形态进行了独立评估。当观察到峰值活动时间延迟超过5分钟或肾图形态转变为梗阻或无功能模式时,CP-RG也被认为是阳性。CRR和肾图变化的敏感性和特异性分别为50%和80%、63%和100%。在BRAS中,仅在单侧肾脏观察到阳性反应,该侧肾脏保持相对良好的肾功能。CP-RG无法区分URAS和BRAS引起的RVH。4例患者在接受手术或血管成形治疗后进行了随访。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验